Wei Song

First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advancedEGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study

Yuankai Shi, L. Wang, Baohui Han et al. · Annals of Oncology · 2017 · 338 citations

Medicine, Oncology, Pharmacotherapy +10

DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer

Zheng Li, Huizi Lei, Min Luo et al. · Gastric Cancer · 2014 · 241 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients

Kui Deng, Chunyan Yang, Qilong Tan et al. · Gynecologic Oncology · 2018 · 168 citations

Medicine, Oncology, Surgery +16

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway

Hong Zhao, Yuming Guo, Shu Li et al. · Oncotarget · 2015 · 154 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

Yunpeng Yang, Jianya Zhou, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2019 · 136 citations

Medicine, Oncology, Pharmacology +16